Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Clanet

Showing results (21-30 of 137) with videos related to

Pageof 14
Sort By:
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Lack of specificity of the traditional criteria for conversion disordersH Chabrol, G Peresson, M Clanet
Pathologie-Biologie|March 1, 1987
[Immunogenetics of multiple sclerosis]M Clanet, A Cambon-Thomsen, A Rascol
Fundamental & Clinical Pharmacology|January 1, 1989
Calcium antagonists and the vestibular system: a critical review of flunarizine as an antivertigo drugO Rascol, M Clanet, J L Montastruc
Revue Neurologique|January 1, 1990
[Conference at the Salpêtrière. March 1989. Rapid paraplegia, chronic arachnoiditis and hemispheric contrast enhancement in the x-ray scanner]A Autret, M Clanet, M B Delisle
Journal of the Neurological Sciences|February 1, 2003
Clinical-MRI correlations in the secondary progressive phase of MS: lessons from the treatment trialsM Clanet, E Cassol, C Manelfe, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
Interferons and multiple sclerosisM Clanet, A Blancher, P Calvas, et al.
Revue Neurologique|January 1, 1992
[Recurrent Neisseria meningitidis meningitis associated with homozygote complement C7 fraction deficiency]G Angibaud, G Durand, A Rascol, et al.
La Revue Du Praticien|September 15, 1991
[New imaging methods by nuclear magnetic resonance in multiple sclerosis]C Mekies, I Berry, C Manelfe, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 6, 2004
Interferon beta-1a in relapsing multiple sclerosis: four-year extension of the European IFNbeta-1a Dose-Comparison StudyM Clanet, L Kappos, H P Hartung, et al.
Revue Neurologique|November 1, 1995
[Potential value of hyperbaric oxygenation in the treatment of post-radiation myelopathies]G Angibaud, J L Ducassé, G Baillé, et al.
Pageof 14

Showing results (21-30 of 137) with videos related to

Sort By:
Pageof 14
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Lack of specificity of the traditional criteria for conversion disordersH Chabrol, G Peresson, M Clanet
Pathologie-Biologie|March 1, 1987
[Immunogenetics of multiple sclerosis]M Clanet, A Cambon-Thomsen, A Rascol
Fundamental & Clinical Pharmacology|January 1, 1989
Calcium antagonists and the vestibular system: a critical review of flunarizine as an antivertigo drugO Rascol, M Clanet, J L Montastruc
Revue Neurologique|January 1, 1990
[Conference at the Salpêtrière. March 1989. Rapid paraplegia, chronic arachnoiditis and hemispheric contrast enhancement in the x-ray scanner]A Autret, M Clanet, M B Delisle
Journal of the Neurological Sciences|February 1, 2003
Clinical-MRI correlations in the secondary progressive phase of MS: lessons from the treatment trialsM Clanet, E Cassol, C Manelfe, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
Interferons and multiple sclerosisM Clanet, A Blancher, P Calvas, et al.
Revue Neurologique|January 1, 1992
[Recurrent Neisseria meningitidis meningitis associated with homozygote complement C7 fraction deficiency]G Angibaud, G Durand, A Rascol, et al.
La Revue Du Praticien|September 15, 1991
[New imaging methods by nuclear magnetic resonance in multiple sclerosis]C Mekies, I Berry, C Manelfe, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 6, 2004
Interferon beta-1a in relapsing multiple sclerosis: four-year extension of the European IFNbeta-1a Dose-Comparison StudyM Clanet, L Kappos, H P Hartung, et al.
Revue Neurologique|November 1, 1995
[Potential value of hyperbaric oxygenation in the treatment of post-radiation myelopathies]G Angibaud, J L Ducassé, G Baillé, et al.
Pageof 14